HOYA Co. (OTCMKTS:HOCPY - Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 15,500 shares, a growth of 167.2% from the April 30th total of 5,800 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily trading volume, of 69,900 shares, the short-interest ratio is presently 0.2 days.
HOYA Stock Down 3.4%
HOYA stock traded down $4.09 during mid-day trading on Friday, reaching $116.98. 116,843 shares of the company were exchanged, compared to its average volume of 38,135. The company has a debt-to-equity ratio of 0.02, a quick ratio of 4.35 and a current ratio of 5.04. The firm has a market cap of $40.14 billion, a P/E ratio of 29.77, a PEG ratio of 2.38 and a beta of 0.93. The business has a fifty day moving average of $115.93 and a 200 day moving average of $122.88. HOYA has a 12-month low of $97.49 and a 12-month high of $148.27.
HOYA (OTCMKTS:HOCPY - Get Free Report) last issued its earnings results on Thursday, May 1st. The technology company reported $0.98 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.99 by ($0.01). HOYA had a net margin of 24.17% and a return on equity of 21.34%. The company had revenue of $1.52 billion during the quarter, compared to analyst estimates of $1.50 billion. Research analysts anticipate that HOYA will post 3.66 earnings per share for the current fiscal year.
Analyst Ratings Changes
Separately, Erste Group Bank upgraded HOYA from a "hold" rating to a "strong-buy" rating in a report on Friday, May 23rd.
Read Our Latest Stock Analysis on HOYA
About HOYA
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
See Also
Before you consider HOYA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HOYA wasn't on the list.
While HOYA currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
